Amfil Technologies Inc (FUNN)

[recinvestor]

Many pure MJ plays have overinflated market caps, with no incoming revenues.

Anything MJ has been the darling of the OTC for several years running now. Market participants have turned a blind eye to fundamentals of these companies, as generally they do with most OTC trades. However much like the dot com era, some of these MJ stocks will make it big and that's why I believe some of these MJ companies are still able to hold their overinflated market caps. Eventually the creme de la creme will see their fundamentals catch up with their current market caps.

If AMFE starts seeing ANY revenues from the GROzone division, regardless of how it breaks down with respect to the various "outside" parties' percentage take, I believe it's possible AMFE can not only achieve a high market cap in the hundreds of millions, but can also support it with fundamentals, purely because the company WILL have revenues unlike many other MJ stocks that have ridiculous valuations. Additionally, Snakes will be providing huge streams of revenue.

There may be some validity to what some have stated here, that our next needed catalyst that will move the share price, has to be from the GROzone division.

But I'm still seeing in the charts that what's keeping us in this channel is more technical than anything to do with not having solidified deals via GROzone.

If the timing of both technical and an announced deal via GROzone come together simultaneously, we can have a trifecta response in share price appreciation from chart set up, GROzone deal, and Snakes recent press.

Kind of addressed your question and went off in another direction. Point being, I wouldn't worry about the division of revenues percentage wise.
If we're getting revenues from anything MJ, we can see similar crazy market caps like any other MJ play. Better yet, AMFE isn't a pure MJ play like those others. AMFE also has their other divisions bringing in strong revenues.

Go AMFE
Rec